Improving Glycemic Control on GMS: A Quality Improvement Study
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will examine whether new processes and technologies for monitoring diabetic patients' insulin levels improves patient care at Brigham and Women's Hospital.
| Condition | Intervention |
|---|---|
|
Diabetes Mellitus |
Behavioral: Order Set, Education, Feedback |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind Primary Purpose: Treatment |
| Official Title: | Improving Glycemic Control on GMS: A Quality Improvement Study |
- - Point-of-care testing glucose values (percent of routine glucose readings between 60 and 180 mg/dL)
- - Lab glucose values (percent of routine glucose readings between 60 and 180 mg/dL)
- - Quality of insulin orders using explicit criteria
| Estimated Enrollment: | 1100 |
| Study Start Date: | May 2010 |
| Estimated Study Completion Date: | March 2011 |
| Estimated Primary Completion Date: | March 2011 (Final data collection date for primary outcome measure) |
This study will examine whether new processed and technologies for monitoring diabetic patients' insulin levels improves patient care. Patients at Brigham and Women's Hospital (BWH), staying on the General Medicine Service, who have Type 2 diabetes and who are not on IV insulin can participate in this study. Physicians and nurses will be taught new rules to care for diabetic patients, while in the hospital. Also, the BWH computer system will be updated to include these new rules for administering insulin. Patients who participate in the study will be randomly placed into one of two groups: one group that will be cared for by physicians and nurses who have learned these new rules for administering insulin; or the second group, who will receive diabetes care at BWH before the new rules were adopted. The study will last approximately 1 year.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Subjects will include all type 2 diabetic patients on the General Medicine Service (GMS) of Brigham and Women's Hospital (BWH) who do not have an indication for IV insulin.
Exclusion Criteria:
- Type 2 diabetic patients on the General Medicine Service (GMS) of Brigham and Women's Hospital (BWH) who have an indication for IV insulin.
Contacts and Locations| Contact: Jeffrey L. Schnipper, MD, MPH | 617-732-6201 | jschnipper@partners.org |
| United States, Massachusetts | |
| Brigham and Women's Hospital | Not yet recruiting |
| Boston, Massachusetts, United States, 02120 | |
| Principal Investigator: | Jeffrey L Schnipper, MD, MPH | Brigham and Women's Hospital |
More Information
No publications provided
| Responsible Party: | Jeffrey L. Schnipper, MD, MPH, Brigham & Women's Hospital |
| ClinicalTrials.gov Identifier: | NCT00271700 History of Changes |
| Other Study ID Numbers: | 2005-P-001880/1, 2005-P-001880/1 |
| Study First Received: | December 30, 2005 |
| Last Updated: | May 3, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Brigham and Women's Hospital:
|
Diabetes Mellitus Outcome Assessment (Healthcare) Inpatients Hospital Information Systems Education |
Additional relevant MeSH terms:
|
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013